Marrone Bio Innovations, Inc.
MBII
MBII was delisted on the 12th of July, 2022.
23 hedge funds and large institutions have $8.92M invested in Marrone Bio Innovations, Inc. in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 5 closing their positions.
12% less funds holding
Funds holding: 26 → 23 (-3)
23% less capital invested
Capital invested by funds: $11.6M → $8.92M (-$2.67M)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
71% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FANJ
Financial Architects (New Jersey)
Marlton,
New Jersey
|
+$1.51K |
| 2 |
Goldman Sachs
New York
|
+$1.47K |
| 3 |
GBBWRPM
Genovese Burford & Brothers Wealth & Retirement Plan Management
Sacramento,
California
|
+$1.11K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$188 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Senvest Management
New York
|
-$320K |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$169K |
| 3 |
Millennium Management
New York
|
-$24.3K |
| 4 |
Primecap Management
Pasadena,
California
|
-$24.3K |
| 5 |
SIP
Stoneridge Investment Partners
Radnor,
Pennsylvania
|
-$14K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
JP Morgan Chase
New York
| – | -$1K | -629 | Closed |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| – | +$188 | +187 | New |
|
MBII Hedge Fund Activity: Q1 2016 in Review
23 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q1 2016, worth a combined $8.92M — down 23% from $11.6M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of MBII and 2 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 2 added.
The largest buyer was Financial Architects (New Jersey), opening a new position worth an estimated $1.51K. The largest seller was Senvest Management, cutting an estimated $320K.
- 23 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q1 2016, down from 26 in Q4 2015.
- Funds reported $8.92M of Marrone Bio Innovations, Inc. stock for Q1 2016, down 23% quarter-over-quarter.
- 2 funds opened new Marrone Bio Innovations, Inc. positions in Q1 2016 and 5 closed out, a net change of -3 holders.
- The largest Marrone Bio Innovations, Inc. buyer in Q1 2016 was Financial Architects (New Jersey), an estimated $1.51K added.
- The largest Marrone Bio Innovations, Inc. seller in Q1 2016 was Senvest Management, an estimated $320K sold.
Based on aggregated 13F filings for Q1 2016.